Shannon John Patrick Jr
SEC CIK 1553595 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | See Remarks, Dir | 2.90M | $260.1K | $349.7K | 19 | 2021-10-05 | 2026-08-01 |
Most active insiders at XERS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hecht Beth | See Remarks | — | $1.31M |
| 2 | McCulloch Kevin | See Remarks | — | $1.09M |
| 3 | JOHNSON JOHN | Dir | — | $1.07M |
| 4 | Pieper Steven | See Remarks | — | $468.2K |
| 5 | Shannon John Patrick Jr | See Remarks, Dir | — | $349.7K |
| 6 | BORMANN-KENNEDY BARBARA-JEAN ANNE | Dir | — | $203.9K |
| 7 | HALKUFF DAWN | Dir | — | $121.9K |
| 8 | PERSKY MARLA | Dir | — | $91.4K |
| 9 | Brady James Aloysius | Dir | — | $60.0K |
| 10 | Nguyen Anh Tu | See Remarks | — | — |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-21 16:23 | 2026-08-01 | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks, Dir | F - Tax | $8.08 | -36.6K | 2.90M | -1% | -$296.1K | |
| D | 2026-02-02 | 2026-01-30 | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks, Dir | A - Grant | $0.00 | +478.4K | 3.28M | +17% | $0 |
| DM | 2026-02-02 | 2026-01-31 | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks, Dir | F - Tax | $7.36 | -340.5K | 3.16M | -10% | -$2.51M |
| D | 2026-01-06 | 2026-01-05 | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks, Dir | S - Sale+OE | $7.08 | -24.9K | 2.71M | -0.9% | -$176.3K |
| DM | 2026-01-06 | 2026-01-05 | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks, Dir | M - OptEx | $1.63 | +92.3K | 2.77M | +3% | +$150.0K |
| DM | 2025-11-17 | 2025-11-13+ | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks, Dir | M - OptEx | $1.55 | +96.1K | 2.73M | +4% | +$148.9K |
| D | 2025-11-17 | 2025-11-13 | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks, Dir | S - Sale+OE | $7.46 | -23.2K | 2.64M | -0.9% | -$173.4K |
| 2025-08-04 | 2025-08-01 | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks, Dir | F - Tax | $5.38 | -36.9K | 2.66M | -1% | -$198.6K | |
| DM | 2025-02-03 | 2025-01-31 | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks, Dir | F - Tax | $3.56 | -221.5K | 2.00M | -10% | -$788.5K |
| D | 2025-02-03 | 2025-01-31 | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks, Dir | A - Grant | $0.00 | +800.0K | 2.69M | +42% | $0 |
| 2025-01-07 | 2025-01-03 | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks, Dir | F - Tax | $3.61 | -39.4K | 2.11M | -2% | -$142.4K | |
| DM | 2024-08-02 | 2022-01-29+ | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks, Dir | F - Tax | $2.06 | -271.6K | 2.32M | -10% | -$559.8K |
| D | 2024-08-02 | 2024-08-01 | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks, Dir | A - Grant | $0.00 | +250.0K | 2.42M | +12% | $0 |
| 2024-01-31 | 2024-01-31 | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks | A - Grant | $0.00 | +750.0K | 2.16M | +53% | $0 | |
| 2023-11-17 | 2023-11-17 | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks | P - Purchase | $1.64 | +30.8K | 1.41M | +2% | +$50.5K | |
| 2023-02-01 | 2023-01-31 | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks | A - Grant | $0.00 | +750.0K | 1.38M | +119% | $0 | |
| 2022-01-05 | 2022-01-03 | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks | A - Grant | $0.00 | +250.0K | 618.9K | +68% | $0 | |
| M | 2021-11-12 | 2021-11-11+ | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks | P - Purchase | $2.10 | +100.0K | 363.8K | +38% | +$209.6K |
| DM | 2021-10-05 | 2021-10-05 | XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks | A - Grant | — | +263.8K | 263.8K | New | — |
Purchase Sale Sale after option exercise All abbreviations